| pubmed-article:17679724 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17679724 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:17679724 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:17679724 | lifeskim:mentions | umls-concept:C0728747 | lld:lifeskim |
| pubmed-article:17679724 | pubmed:issue | 25 | lld:pubmed |
| pubmed-article:17679724 | pubmed:dateCreated | 2007-8-31 | lld:pubmed |
| pubmed-article:17679724 | pubmed:abstractText | In human epidermal growth factor 2 (HER-2)-positive advanced breast cancer, taxanes or vinorelbine plus trastuzumab are among the most widely applied options in the first-line setting. We evaluated the efficacy and tolerability of capecitabine plus trastuzumab after anthracycline and docetaxel or vinorelbine failure and prior trastuzumab exposure. | lld:pubmed |
| pubmed-article:17679724 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17679724 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17679724 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17679724 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17679724 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:StegerGuenthe... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:WenzelCathari... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:ZielinskiChri... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:GnantMichaelM | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:PluschnigUrsu... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:RudasMargaret... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:MaderRobert... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:BartschRupert... | lld:pubmed |
| pubmed-article:17679724 | pubmed:author | pubmed-author:AltorjaiGabri... | lld:pubmed |
| pubmed-article:17679724 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17679724 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17679724 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:17679724 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17679724 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17679724 | pubmed:pagination | 3853-8 | lld:pubmed |
| pubmed-article:17679724 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:meshHeading | pubmed-meshheading:17679724... | lld:pubmed |
| pubmed-article:17679724 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17679724 | pubmed:articleTitle | Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer. | lld:pubmed |
| pubmed-article:17679724 | pubmed:affiliation | First Department of Medicine and Cancer Centre, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria. | lld:pubmed |
| pubmed-article:17679724 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17679724 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17679724 | lld:pubmed |
